In the last trading session, 1.38 million shares of the Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) were traded, and its beta was -0.15. Most recently the company’s share price was $2.08, and it changed around $0.01 or 0.48% from the last close, which brings the market valuation of the company to $96.88M. RVPH currently trades at a discount to its 52-week high of $4.83, offering almost -132.21% off that amount. The share price’s 52-week low was $0.60, which indicates that the current value has risen by an impressive 71.15% since then. We note from Reviva Pharmaceuticals Holdings Inc’s average daily trading volume that its 10-day average is 1.3 million shares, with the 3-month average coming to 2.89 million.
Reviva Pharmaceuticals Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended RVPH as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Reviva Pharmaceuticals Holdings Inc is expected to report earnings per share of -0.22 for the current quarter.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Instantly RVPH has showed a green trend with a performance of 0.48% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.15 on recent trading dayincreased the stock’s daily price by 3.26%. The company’s shares are currently up 14.92% year-to-date, but still up 10.05% over the last five days. On the other hand, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is 4.00% up in the 30-day period. We can see from the shorts that 5.3 million shares have been sold at a short interest cover period of 19.04 day(s).
Forecasts for the next quarter put sales growth at 0.00%.
Reviva Pharmaceuticals Holdings Inc earnings are expected to increase by 40.26% in 2025, but the outlook is positive 20.47% per year for the next five years.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc’s next quarterly earnings report is expected to be released in March.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.79% of Reviva Pharmaceuticals Holdings Inc shares, and 30.07% of them are in the hands of institutional investors. The stock currently has a share float of 35.28%. Reviva Pharmaceuticals Holdings Inc stock is held by 35.0 institutions, with WOODLINE PARTNERS LP being the largest institutional investor. By 2024-06-30, it held 6.6273% of the shares, which is about 1.59 million shares worth $2.04 million.
MILLENNIUM MANAGEMENT LLC, with 5.1656% or 1.24 million shares worth $1.59 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 700.44 shares worth $1.46 million, making up 2.09% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 312.3 shares worth around $0.65 million, which represents about 0.93% of the total shares outstanding.
